Aemetis to Review Fourth Quarter Financial Results on March 24, 2016

CUPERTINO, CA -- (Marketwired) -- 03/21/16 -- Aemetis, Inc. (NASDAQ: AMTX) announced that the company will host an earnings review call regarding the release of its fourth quarter 2015 earnings report:

Date: Thursday, March 24, 2016

Time: 10 am Pacific Time (PT)

Live Participant Dial In (Toll Free): +1 (877) 407-8133
Live Participant Dial In (International): +1 (201) 689-8040
Webcast URL:

Attendees may submit questions during the Q&A portion of the conference call.

After March 24th, the webcast will be available on the Company's website ( under Investors/Conference Calls. The voice recording will also be available through March 31, 2016 by dialing +1 (877) 660-6853 (Toll Free) or +1 (201) 612-7415 (International) and entering conference ID number 13631890.

About Aemetis
Headquartered in Cupertino, California, Aemetis is an advanced renewable fuels and biochemicals company focused on the acquisition, development, and commercialization of innovative technologies that replace traditional petroleum-based products by the conversion of first-generation ethanol and biodiesel plants into advanced biorefineries. Founded in 2006, Aemetis owns and operates a 60 million-gallon-per-year ethanol production facility in the California Central Valley near Modesto. Aemetis also owns and operates a 50 million-gallon-per-year renewable chemical and advanced fuel production facility on the East Coast of India, producing high quality distilled biodiesel and refined glycerin for customers in India and Europe. Aemetis operates a research and development laboratory at the Maryland Biotech Center, and holds a portfolio of patents and related technology licenses for the production of renewable fuels and biochemicals. For additional information about Aemetis, please visit

Company/Media/ Investor Relations Contact:
Satya Chillara
(408) 213-0939

Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.